| Richard Stewart, MD | |
|
1332 Vivian St, Longmont, CO 80501-3217 | |
| (303) 485-1516 | |
| (303) 776-1110 |
| Full Name | Richard Stewart |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 1332 Vivian St, Longmont, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932113578 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | DR44039 (Colorado) | Primary |
| Entity Name | Glaucoma Consultants Of Colorado Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447201009 PECOS PAC ID: 9335053081 Enrollment ID: O20040601001423 |
News Archive
ConvergeHEALTH by Deloitte and the Regenstrief Institute, Inc. are announcing that Regenstrief, an internationally recognized informatics and health care research organization, has become a member of ConvergeHEALTH's real-world evidence and analytics consortium.
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.
› Verified 8 days ago
| Entity Name | Flatirons Ophthalmology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942523543 PECOS PAC ID: 7315343290 Enrollment ID: O20210831003240 |
News Archive
ConvergeHEALTH by Deloitte and the Regenstrief Institute, Inc. are announcing that Regenstrief, an internationally recognized informatics and health care research organization, has become a member of ConvergeHEALTH's real-world evidence and analytics consortium.
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Stewart, MD 1332 Vivian St, Longmont, CO 80501-3217 Ph: (303) 485-1516 | Richard Stewart, MD 1332 Vivian St, Longmont, CO 80501-3217 Ph: (303) 485-1516 |
News Archive
ConvergeHEALTH by Deloitte and the Regenstrief Institute, Inc. are announcing that Regenstrief, an internationally recognized informatics and health care research organization, has become a member of ConvergeHEALTH's real-world evidence and analytics consortium.
Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.
› Verified 8 days ago
William L Benedict, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-3300 Fax: 303-682-3380 | |
Aimee Morris Verner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-3300 Fax: 303-682-3380 | |
Mohammad Karbassi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 205 S Main St, Suite D, Longmont, CO 80501 Phone: 303-772-3611 Fax: 303-772-3609 | |
Micah W Rothstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-3300 Fax: 303-682-3380 | |
Irene Olijnyk, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-3300 Fax: 303-682-3380 | |
Dr. Dale S. Johnson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1319 Vivian St, Longmont, CO 80501 Phone: 303-772-3611 Fax: 303-772-3609 | |
Diane Towako Siegel, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1400 Dry Creek Dr, Longmont, CO 80503 Phone: 303-772-3300 Fax: 303-682-3380 |